November 7, 2007 (Orlando, FL) – Using genetic tests as well as clinical factors improved the accuracy and efficiency of warfarin dose initiation, but the primary end point of a reduction in ...
WASHINGTON (March 19, 2017) - Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse ...
Expert Rev Pharmacoeconomics Outcomes Res. 2010;10(4):375-378. Patients with a variant genotype have a higher risk of bleedings due to warfarin therapy, because of a lower dose requirement. A genotype ...
St. Louis, Feb. 18, 2009 — Each year in the United States, doctors start about 2 million patients on warfarin (Coumadin™), an anticoagulant drug that's notoriously hard to administer. Now a study from ...
Blood thinners are often prescribed to prevent life-threatening clots. One type, called direct oral anticoagulants (DOACs), ...
In this session, data were presented from 3 separate trials that focused on potential ways to reduce the risk for bleeding in patients who require anticoagulation therapy, including the use of genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback